Kits (2)
Launched (2)
- (2)
- (2)
- (2)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
RES-A024 | - | - | resDetect™ Universal Protein A Quick ELISA kit | ||||
RES-A029 | - | - | resDetect™ Universal Protein A Quick ELISA Kit (Boiling-free) |
| English Name | Research Code | Highest Development Stage | Company | Earliest Brand Name | Earliest Approval Country | Earliest Indication | Earliest Approval Company | Earliest Approval Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Nemolizumab | CD-14152; CIM-331 | Approved | Chugai Pharmaceutical Co Ltd | Mitchga, Nemluvio | Japan | Pruritus; Dermatitis, Atopic | Maruho Co Ltd | 2022-03-28 | Pruritus; Scleroderma, Systemic; Prurigo; Renal Insufficiency, Chronic; Dermatitis, Atopic | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



